NEW YORK (360Dx) – Gemelli Biotech today announced a deal by which Advanced Medical German (AMG) will distribute its diagnostic blood test for irritable bowel syndrome.

Gemelli said that AMG, which is based in Kuwait, will begin distributing the test, IBS-smart, starting in the spring of 2019 in parts of the Middle East and North Africa, including Kuwait, United Arab Emirates, Qatar, Saudi Arabia, Egypt, and Turkey, among others.

Financial and other terms of the deal were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.